Determinants of Appropriate Use of Angiotensin-Converting Enzyme Inhibitors After Acute Myocardial Infarction in Persons ≥65 Years of Age
- 1 March 1997
- journal article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 79 (5), 581-586
- https://doi.org/10.1016/s0002-9149(96)00819-3
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Aspirin in the Treatment of Acute Myocardial Infarction in Elderly Medicare BeneficiariesCirculation, 1995
- Angiotensin-converting enzyme inhibitor use in survivors of acute myocardial infarctionThe American Journal of Cardiology, 1995
- Quality of Care for Medicare Patients With Acute Myocardial InfarctionJAMA, 1995
- Knowledge and Practices of Generalist and Specialist Physicians Regarding Drug Therapy for Acute Myocardial InfarctionNew England Journal of Medicine, 1994
- The Uniform Clinical Data Set: An Evaluation of the Proposed National Database for Medicare's Quality Review ProgramAnnals of Internal Medicine, 1993
- Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 1992
- The Health Care Quality Improvement InitiativePublished by American Medical Association (AMA) ,1992
- Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.Circulation, 1990
- Effect of Captopril on Progressive Ventricular Dilatation after Anterior Myocardial InfarctionNew England Journal of Medicine, 1988
- Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril.Circulation, 1985